Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
35 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128007 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-06 | 2020-11-12 | 128037 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-27 | 2021-02-11 | 129045 |
TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-01-15 | 2021-02-11 | 131694 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2021-03-18 | 2021-04-21 | 135965 |
TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-07-22 | 2021-09-02 | 142905 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-29 | 2021-11-05 | 143262 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-08-13 | 2021-10-07 | 144111 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-09-23 | 2021-10-07 | 146118 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-01-27 | 2022-02-05 | 153715 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155174 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-08-18 | 2022-09-08 | 167241 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181617 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183422 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-02-09 | 2023-04-28 | 184189 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-06-26 | 2023-07-06 | 196427 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 199053 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-07-27 | 2023-10-12 | 200240 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-08-03 | 2023-10-04 | 200910 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42613 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |